Target intelligence / Profile preview

RNA, U6 small nuclear 380, pseudogene (RNU6-380P)

Target
RNU6-380P
Molecular classification
Other, Pseudogene, Non-coding RNA pseudogene
01

Overview

RNU6-380P, or RNA, U6 small nuclear 380, pseudogene, is classified as a pseudogene related to the U6 small nuclear RNA (snRNA) family. The functional U6 snRNA is a highly conserved non-coding RNA that is fundamental to the spliceosome, the molecular machinery responsible for removing introns from pre-mRNA during RNA splicing[1][3]. The U6 snRNA is essential for spliceosome catalysis, directly coordinating catalytic metal ions and forming part of the spliceosomal active site[1][3]. However, by definition, a pseudogene such as RNU6-380P is a genomic sequence similar to a functional gene but is generally nonfunctional due to mutations, deletions, or lack of proper regulatory elements[5]. Pseudogenes like RNU6-380P do not produce functional snRNA molecules and are not known to have a direct role in RNA splicing or other biological processes. They are not considered therapeutic targets, and there is no evidence linking RNU6-380P to disease mechanisms, drug interactions, or biomarker utility. The presence of U6 snRNA pseudogenes in the genome highlights the evolutionary importance of U6 but does not ascribe functional or therapeutic significance to these specific pseudogenes[3][5]. If you are seeking information on the canonical, functional U6 snRNA, it should be distinguished from its pseudogenes[1][3][5].

Other names
RNU6-380PRNA, U6 small nuclear 380, pseudogene
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on RNA, U6 small nuclear 380, pseudogene (RNU6-380P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 380, pseudogene (RNU6-380P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call